-
Featured
Mortality in COVID-19 Does Not Appear to Be Driven by Liver Failure
Massachusetts General Hospital researchers report that elevated liver function tests are common in COVID-19, but severe liver injury is rare, and no case of liver failure or dysfunction leading to death has been attributed directly to COVID-19.
-
Featured
Patients with Decompensated Cirrhosis Need Earlier End-of-Life Planning
Regardless of transplant candidacy, patients with decompensated cirrhosis spend a substantial portion of their last 90 days of life in the hospital, are likely to receive intensive interventions at the end of life and tend to be referred late, if at all, to palliative or hospice care.
-
Featured
Early Transplantation for Alcohol-associated Hepatitis Improves Survival
According to a mathematical model, offering liver transplantation with no minimum period of sobriety before surgery (i.e., early liver transplantation) for severe alcohol-associated hepatitis provides a fourfold increase in life expectancy compared with requiring a six-month period of sobriety before listing. having characteristics similar to patients in ACCELERATE-AH trial.
-
Cardiovascular Disease Risk Elevated in Children and Young Adults With NAFLD
Tracey G. Simon, MD, MPH, and colleagues have provided the first nationwide estimate of cardiovascular risk in children and young adults with nonalcoholic fatty liver disease, finding the disease doubles the risk of incident major adverse cardiovascular events and triples the risk of incident arrhythmia.
-
Risk Factors Identified for Cardiovascular Disease in Individuals With Hepatic Steatosis
Kathleen E. Corey, MD, MPH, MMSc, Júlia Karády, MD, and colleagues conducted the first study of risk factors for cardiovascular disease risk in patients with hepatitis steatosis based on comprehensive baseline profiling as well as prospective analysis of major adverse cardiovascular events.
-
Treating Liver Cancer Using Hepatic Arterial Infusion Pumps
Physicians at Massachusetts General Hospital are refining the use of hepatic arterial infusion pumps for targeted delivery of chemotherapy to treat liver metastases.
Liver Contributors
-
Emily D. Bethea, MD
Associate Clinical Director of Liver Transplantation, Massachusetts General Hospital
-
Jagpreet Chhatwal, PhD
Associate Director, Institute for Technology Assessment, Assistant Professor, Harvard Medical School
Recent Article
County-level COVID-19 Data Confirms Effectiveness of Workplace Closure
-
Kathleen E. Corey, MD, MPH, MMSc
Director, Fatty Liver Clinic, Mass General Gastrointestinal Unit, Associate Professor of Medicine, Harvard Medical School
Recent Article
Risk Factors Identified for Cardiovascular Disease in Individuals With Hepatic Steatosis
-
Raymond T. Chung, MD
Vice Chief, Division of Gastroenterology, Director, Hepatology and Liver Center, Massachusetts General Hospital
Recent Article
Monitoring Novel HBV Markers Worthwhile in HBeAg-positive Patients Coinfected With HIV
-
Russell P. Goodman, MD, DPhil
Hepatologist, Division of Gastroenterology, Massachusetts General Hospital, Instructor in Medicine, Harvard Medical School
Recent Article
Imbalance of Electrons in the Liver May Be A Risk Factor for Many Common Diseases
Digestive Healthcare at Mass General
The Massachusetts General Hospital Digestive Healthcare Center is a collaborative practice of gastroenterologists, endoscopists, surgeons, radiologists, pathologists, hepatologists, oncologists and radiation oncologists dedicated to the prevention, diagnosis, treatment and management of digestive diseases.